The interleukin 6 -572 G>C (rs1800796) polymorphism is associated with the risk of developing acute coronary syndrome

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 6, 2010, Pages 759-763

  Fragoso, José Manuel ^a,b   Delgadillo, Hilda ^a   Juárez Cedillo, Teresa ^c   Rodríguez Pérez, José Manuel ^a   Vallejo, Maite ^a   Pérez Méndez, Oscar ^a   Álvarez León, Edith ^a   Peña Duque, Marco Antonio ^a   Martínez Ríos, Marco Antonio ^a   Vargas Alarcón, Gilberto ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EXONUCLEASE; GAMMA INTERFERON; INTERLEUKIN 6;

5' UNTRANSLATED REGION; ACUTE CORONARY SYNDROME; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; RISK FACTOR; WILD TYPE;

ACUTE CORONARY SYNDROME; AGED; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78650345242     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0001     Document Type: Article

References (40)

1. Abeywardena MY, Leifert WR, Warnes KE, et al. (2009) Cardiovascular biology of interleukin-6. Curr Pharm Des 15:1809-1821.
2. Achar SA, Kundu S, Norcross WA (2005) Diagnosis of acute coronary syndromes. Am Fam Physician 72:119-126.
3. Amento EP, Ehsani N, Palmer H, Libby P (1991) Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 11:1223-1230.
4. Angerio AD (2009) Interferon and heart disease. Crit Care Nurs Q 32:159-162.
5. Aukrust P, Halvorsen B, Yndestad A, et al. (2008) Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 28:1909-1919.
6. Barbulescu K, Meyer zum Büschenfelde KH, Neurath MF (1997) Constitutive and inducible protein/DNA interactions of the interferon-gamma promoter in in vivo CD45RA and CD45R0 T helper subsets. Eur J Immunol 27:1098-1107.
7. Bream JH, Ping A, Zhang X, et al. (2002) A single polymorphism in the proximal INF-gamma promoter alters control of gene transcription. Genes Immun 3:165-169.
8. Brull DJ, Montgomery HE, Sanders J, et al. (2001) Interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21:1458-1463.
9. Dienz O, Rincon M (2009) The effects of IL-6 on CD4 T cell responses. Clin Immunol 130:27-33.
10. Fonseca JE, Santos MJ, Canhão H, Choy E (2009) Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 8:538-542.
11. Fragoso JM, Ramírez-Bello J, Cruz-Robles D, et al. (2009) Proinflammatory and anti-inflammatory markers in coronary artery disease and acute ischemic coronary syndrome. Arch Cardiol Mex 79:54-62.
12. Fu HX, Li GS, Li Y, et al. (2006) Interleukin-6-597G/A and -572C/G polymorphisms and risk of coronary artery disease. Zhonghua Xin Xue Guan Bing Za Zhi 34:519-522.
13. Gabriel AS, Ahnve S, Wretlind B, Martinsson A (2000) IL-6 and IL-1 receptor antagonist instable angina pectoris and relation of IL-6 to clinical findings in acute myocardial infarction. J Intern Med 248:61-66.
14. Garcia-Moll X (2005) Inflammatory and anti-inflammatory markers in acute coronary syndromes. Ready for use in the clinical setting? Rev Esp Cardiol 58:615-617.
15. Gordon A, Kiss-Toth E, Stockley I, et al. (2008) Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. Arthritis Rheum 58:3157-3165.
16. Heinisch RH, Zanetti CR, Comin F, et al. (2005) Serial changes in plasma levels of cytokines in patients with coronary artery disease. Vasc Health Risk Manage 1:245-250.
17. Holla LI, Fassmann A, Stejskalová A, et al. (2004) Analysis of the interleukin-6 gene promoter polymorphisms in Czech patients with chronic periodontitis. J Periodontol 75:30-36.
18. Huang Y, Yang H, Borg BB, et al. (2007) A functional SNP of interferon-g gene is important for interferon-a-induced and spontaneous recovery from hepatitis C virus infection. Proc Natl Acad Sci U S A 104:985-990.
19. Humphries SE, Loung LA, Ogg MS, et al. (2001) The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22:2243-2252.
20. Jang Y, Kim OY, Hyun YJ, et al. (2008) Interleukin-6-572C>G polymorphism-association with inflammatory variables in Korean men with coronary artery disease. Transl Res 151:154-161.
21. Kitamura A, Hasegawa G, Obayashi H, et al. (2002) Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 19:1000-1005.
22. Koch O, Rockett K, Jallow M, et al. (2005) Investigation of malaria susceptibility determinants in the INFG/IL26/IL22 genomic region. Genes Immun 6:312-318.
23. Koh SJ, Jang Y, Hyun YJ, et al. (2009) Interleukin-6 (IL-6) -572C/G promoter polymorphism is associated with type 2 diabetes risk on Koreans. Clin Endocrinol (Oxf) 70:238-244.
24. Komatsu Y, Tai H, Galicia JC, et al. (2005) Interleukin-6 (IL-6)-373 A9T11 allele is associated with reduced susceptibility to chronic periodontitis in Japanese subjects and decreased serum IL-6 level. Tissue Antigens 65:110-114.
25. Lahiri DK, Nurnberger JI Jr. (1991) A rapid non-enzymatic method for the preparation HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
26. Libby P (2002) Inflammation and atherosclerosis. Nature 420:868-874.
27. Mälarstig A, Eriksson P, Hamsten A, et al. (2006) Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome. Heart 94:724-729.
28. Mälarstig A, Wallentin L, Siegbahn A (2007) Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome. Thromb Res 119:467-473.
29. Mouco OM, Nicolau JC, Souza Tda R, et al. (2005) Inflammatory markers of atherosclerotic plaque stabilization after acute coronary event-temporal trends. Arq Bras Cardiol 87:28-36.
30. Pasqui AL, Di Renzo M, Bova G, et al. (2006) Pro-inflammatory/anti- inflammatory cytokine imbalance in acute coronary syndromes. Clin Exp Med 6:38-44.
31. Qi L, van Dam RM, Meigs JB, et al. (2006) Genetic variation in IL-6 and type 2 diabetes: tagging-SNP Haplotype analysis in large-scale case-controls study and meta-analysis. Hum Mol Genet 15:1914-1920.
32. Qi S, Cao B, Jiang M, et al. (2005) Association of the -183 polymorphisms in the INF-g gene promoter with hepatitis B virus infection in the Chinese population. J Clin Lab Anal 19:276-281.
33. Richardson P, McKenna W, Bristow M, et al. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task force on the definition and classification of cardiomyopathies. Circulation 93: 841-842.
34. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and risk of future myocardial infarction among apparently healthy men. Circulation 101: 1767-1772.
35. Ross R (1999) Atherosclerosis an inflammatory disease. N Engl J Med 340:115-126.
36. Shao MY, Huang P, Cheng R, Hu T (2009) Interleukin-6 polymorphisms modify the risk of periodontitis: a systematic review and meta-analysis. J Zhejiang Univ Sci B 10: 920-927.
37. Tanaka C, Mannami T, Kamide K, et al. (2005) Single nucleotide polymorphisms in the interleukin-6 gene associated with blood pressure and atherosclerosis in Japanese general population. Hypertens Res 28:35-41.
38. Virmani R, Kolodgie FD, Burke AP, et al. (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25:2054-2061.
39. Wang YN, Che SM, Ma AQ (2004) Clinical significance of serum cytokines IL-1beta, sIL-2R, IL-6, TNF-alpha, and INF-g in acute coronary syndrome. Chin Med Sci J 19:120-124.
40. Wong LY, Leung RY, Ong KL, Cheung BM (2007) Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension. J Hum Hypertens 21:875-882.